Literature DB >> 23759798

Predictive value of adiponectin in patients with multivessel coronary atherosclerosis detected on computed tomography angiography.

Morihiro Matsuda1, Ritsu Tamura, Naoko Kishida, Takatsugu Segawa, Kotaro Kanno, Orie Nishimoto, Kei Nakamoto, Hirohiko Nishiyama, Toshiharu Kawamoto.   

Abstract

AIM: Multislice computed tomography coronary angiography (CTCA) can be used to detect coronary plaques that predict the risk of cardiovascular events. This study aimed to identify the risk factors associated with the extent of coronary plaques detected using CTCA and to determine the value of adiponectin measurement for identifying high-risk patients with multivessel coronary atherosclerosis.
METHODS: The study included 298 patients who underwent CTCA for coronary artery disease (CAD) screening between July 2008 and October 2011. We investigated the relationship between the extent of coronary atherosclerosis in terms of the number of diseased vessels and various risk factors, including the serum adiponectin level.
RESULTS: The adiponectin level was found to be significantly associated with multivessel coronary atherosclerosis in a univariate analysis (p=0.001). A multivariate analysis revealed the adiponectin level to also be significantly associated with multivessel coronary atherosclerosis (p=0.01), independent of other significant risk factors, including an advanced age, male gender, diabetes mellitus (DM) and hypertension (HT). A receiver operating characteristic curve analysis revealed that a combination of these factors significantly predicted multivessel coronary atherosclerosis (area under the curve, 0.73;95% confidence interval, 0.67-0.78). As the number of these factors increased, the proportion of patients with multivessel coronary atherosclerosis increased, while the proportion of patients with normal coronary arteries decreased (p < 0.0001).
CONCLUSIONS: A low adiponectin level combined with an advanced age, male gender, DM, and HT is independently and incrementally associated with multivessel coronary atherosclerosis. The number of factors may predict the extent of coronary atherosclerosis in patients without documented CAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759798     DOI: 10.5551/jat.18036

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  8 in total

Review 1.  An integrated approach to coronary heart disease diagnosis and clinical management.

Authors:  Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells.

Authors:  Sara Niknam; Keihan Ghatreh-Samani; Effat Farrokhi
Journal:  Int J Mol Cell Med       Date:  2015

3.  Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.

Authors:  Morihiro Matsuda; Ritsu Tamura; Kotaro Kanno; Takatsugu Segawa; Haruyuki Kinoshita; Orie Nishimoto; Hirohiko Nishiyama; Toshiharu Kawamoto
Journal:  Diabetol Metab Syndr       Date:  2013-12-06       Impact factor: 3.320

4.  Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome.

Authors:  Ali Sheikh Md Sayed; Zhenyu Zhao; Lanyan Guo; Fei Li; Xu Deng; Hai Deng; Ke Xia; Tianlun Yang
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

5.  The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study.

Authors:  Takeshi Sakura; Senji Okuno; Eriko Nishio; Kyoko Norimine; Eiji Ishimura; Tomoyuki Yamakawa; Shigeichi Shoji; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

6.  Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.

Authors:  Ken Kishida; Yasuhiko Nakagawa; Hironori Kobayashi; Koji Yanagi; Tohru Funahashi; Iichiro Shimomura
Journal:  Diabetol Metab Syndr       Date:  2014-05-27       Impact factor: 3.320

7.  Association of variant in the ADIPOQ gene and functional study for its role in atherosclerosis.

Authors:  Xinzhong Chen; Yanhong Yuan; Yufeng Gao; Qin Wang; Fei Xie; Dongsheng Xia; Yutao Wei; Ting Xie
Journal:  Oncotarget       Date:  2017-09-23

8.  Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients.

Authors:  Yuri Machiba; Masaaki Inaba; Katsuhito Mori; Masafumi Kurajoh; Kozo Nishide; Kyoko Norimine; Tomoyuki Yamakawa; Shigeichi Shoji; Senji Okuno
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.